Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Barrio

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|March 13, 2025
ASO Author Reflections: What's Inflammation Got to Do With It? Understanding the Pathogenesis of Lymphedema After Axillary SurgeryArielle N Roberts, Andrea V Barrio
JAMA Oncology|May 13, 2022
Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?-ReplyAndrea V Barrio, Giacomo Montagna, Monica Morrow
Advances in Surgery|July 23, 2019
Ductal Carcinoma In Situ of the Breast: Controversies and Current ManagementAndrea V Barrio, Kimberly J Van Zee
Annual Review of Medicine|January 19, 2017
Controversies in the Treatment of Ductal Carcinoma in SituAndrea V Barrio, Kimberly J Van Zee
Annals of Surgical Oncology|June 19, 2015
A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for LymphedemaAndrea V Barrio, Anne Eaton, Thomas G Frazier
JAMA Surgery|August 7, 2024
Social Work's Role in Bridging Breast Cancer Care Gaps-ReplyAndrea V Barrio, Monica Morrow, Babak J Mehrara
Kidney International|March 23, 2007
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trialM Praga, V Barrio, G Fernández Juárez, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 4, 2007
[Does continuous veno-venous hemodiafiltration therapy reduce mortality due to acute renal failure as compared to intermittent hemodialysis?]V Barrio, C Quereda, J Zamora, et al.
Breast Cancer Research and Treatment|July 28, 2025
Axillary dissection is avoidable in most cT1N0 triple-negative & HER2+ breast cancers treated with upfront surgeryAnita Mamtani, Varadan Sevilimedu, Andrea V Barrio, et al.
JAMA Oncology|March 12, 2016
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In SituKimberly J Van Zee, Andrea V Barrio, Julia Tchou, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|March 13, 2025
ASO Author Reflections: What's Inflammation Got to Do With It? Understanding the Pathogenesis of Lymphedema After Axillary SurgeryArielle N Roberts, Andrea V Barrio
JAMA Oncology|May 13, 2022
Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?-ReplyAndrea V Barrio, Giacomo Montagna, Monica Morrow
Advances in Surgery|July 23, 2019
Ductal Carcinoma In Situ of the Breast: Controversies and Current ManagementAndrea V Barrio, Kimberly J Van Zee
Annual Review of Medicine|January 19, 2017
Controversies in the Treatment of Ductal Carcinoma in SituAndrea V Barrio, Kimberly J Van Zee
Annals of Surgical Oncology|June 19, 2015
A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for LymphedemaAndrea V Barrio, Anne Eaton, Thomas G Frazier
JAMA Surgery|August 7, 2024
Social Work's Role in Bridging Breast Cancer Care Gaps-ReplyAndrea V Barrio, Monica Morrow, Babak J Mehrara
Kidney International|March 23, 2007
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trialM Praga, V Barrio, G Fernández Juárez, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 4, 2007
[Does continuous veno-venous hemodiafiltration therapy reduce mortality due to acute renal failure as compared to intermittent hemodialysis?]V Barrio, C Quereda, J Zamora, et al.
Breast Cancer Research and Treatment|July 28, 2025
Axillary dissection is avoidable in most cT1N0 triple-negative & HER2+ breast cancers treated with upfront surgeryAnita Mamtani, Varadan Sevilimedu, Andrea V Barrio, et al.
JAMA Oncology|March 12, 2016
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In SituKimberly J Van Zee, Andrea V Barrio, Julia Tchou, et al.
Pageof 12